← Back to News April 11, 2025

Our research findings have been published in academic journals both in Japan and abroad. (2011–2023)

At our company, we have been publishing the research results obtained through the development of cancer immunotherapies and molecular targeted drugs in multiple peer-reviewed academic journals. Below is a list of papers published since 2011.

Publication date Thesis Title Publication Authors
2023.8 Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapy Cell Reports Kodama M., Toyokawa G., Sugahara O., Sugiyama S., Haratake N., Yamada Y., Wada R., Takamori S., Shimokawa M., Takenaka T., Tagawa T., Kittaka H., Tsuruda T., Tanaka K., Komatsu Y., Nakata K., Imado Y., Yamazaki K., Okamoto I., Oda Y., Takahashi M., Izumi Y., Bamba T., Shimizu H., Yoshizumi T., Nakayama K.I.
2020.5 A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer Nature Communications Kodama M., Oshikawa K., Shimizu H., Yoshioka S., Takahashi M., Izumi Y., Bamba T., Tateishi C., Tomonaga T., Matsumoto M., Nakayama K.I.
2020.12 A second Warburg-like effect in cancer metabolism: The metabolic shift of glutamine-derived nitrogen: A shift in glutamine-derived nitrogen metabolism from glutaminolysis to de novo nucleotide biosynthesis contributes to malignant evolution of cancer BioEssays Kodama M., Nakayama K.I.
2017.5 A large-scale targeted proteomics assay resource based on an in vitro human proteome Nature Methods Matsumoto M., Matsuzaki F., Oshikawa K., Goshima N., Mori M., Kawamura Y., Ogawa K., Fukuda E., Nakatsumi H., Natsume T., Fukui K., Horimoto K., Nagashima T., Funayama R., Nakayama K., Nakayama K.I.
2023.5 Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors Cancer Research Oka T., Higa T., Sugahara O., Koga D., Nakayama S., Nakayama K.I.
2022.5 Spatiotemporal reprogramming of differentiated cells underlies regeneration and neoplasia in the intestinal epithelium Nature Communications Higa T., Okita Y., Matsumoto A., Nakayama S., Oka T., Sugahara O., Koga D., Tateishi S., Nakatsumi H., Hosen N., Robine S., Taketo M.M., Sato T., Nakayama K.I.
2020.12 Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland Cancer Research Onoyama I., Nakayama S., Shimizu H., Nakayama K.I.
2017.7 Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells Nature Communications Muto Y., Nishiyama M., Nita A., Moroishi T., Nakayama K.I.
2015.5 Slowly dividing neural progenitors are an embryonic origin of adult neural stem cells Nature Neuroscience Furutachi S., Miya H., Watanabe T., Kawai H., Yamasaki N., Harada Y., Imayoshi I., Nelson M., Nakayama K.I., Hirabayashi Y., Gotoh Y.
2013.5 Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence Cancer Cell Onoyama I., Naka K., Hirao A., Nakayama K.I.
2011.9 p57 is required for quiescence and maintenance of adult hematopoietic stem cells Cell Stem Cell Matsumoto A., Takeishi S., Kanie T., Susaki E., Onoyama I., Tateishi Y., Nakayama K., Nakayama K.I.

Inquires regarding this matter

AntiCancer Technologies Inc.
E-mail: contact@anticancer.jp